Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients
ObjectiveTo study the possible implication of the two biomarkers, intermediate alleles (IAs) of the Huntingtin (HTT) gene and neurofilament light chain (NfL) levels in plasma, in amyotrophic lateral sclerosis (ALS) patients.MethodsWe analyzed IAs in a cohort of 106 Italian ALS patients and measured...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2021.695049/full |
id |
doaj-b691a160bfff41058884c620d8315433 |
---|---|
record_format |
Article |
spelling |
doaj-b691a160bfff41058884c620d83154332021-09-04T08:21:31ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-09-011510.3389/fnins.2021.695049695049Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS PatientsAssunta Ingannato0Silvia Bagnoli1Salvatore Mazzeo2Valentina Bessi3Sabrina Matà4Monica Del Mastio5Gemma Lombardi6Camilla Ferrari7Sandro Sorbi8Sandro Sorbi9Benedetta Nacmias10Benedetta Nacmias11NEUROFARBA Department, University of Florence, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalySOD Neurologia 1, Dipartimento Neuromuscolo-Scheletrico e Degli Organi di Senso, Azienda Ospedaliero Universitaria Careggi, Florence, ItalySOD Neurologia 1, Dipartimento Neuromuscolo-Scheletrico e Degli Organi di Senso, Azienda Ospedaliero Universitaria Careggi, Florence, ItalyIRCCS Fondazione Don Carlo Gnocchi, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalyIRCCS Fondazione Don Carlo Gnocchi, Florence, ItalyNEUROFARBA Department, University of Florence, Florence, ItalyIRCCS Fondazione Don Carlo Gnocchi, Florence, ItalyObjectiveTo study the possible implication of the two biomarkers, intermediate alleles (IAs) of the Huntingtin (HTT) gene and neurofilament light chain (NfL) levels in plasma, in amyotrophic lateral sclerosis (ALS) patients.MethodsWe analyzed IAs in a cohort of 106 Italian ALS patients and measured the plasma NfL levels in 20% of the patients of the cohort. We correlated the two biomarkers with clinical phenotypes.ResultsIntermediate alleles were present in 7.5% of the patients of our cohort, a frequency higher than that reported in general population. Plasma NfL levels increased with age at onset (p < 0.05). Patients with bulbar onset (BO) had higher plasma NfL concentration (CI −0.61 to −0.06, p = 0.02) and a later age at onset of the disease (CI −24.78 to −4.93, p = 0.006) with respect to the spinal onset (SO) form. Additionally, two of the patients, with IAs and plasma NfL concentration lower with respect to normal alleles’ carriers, presented an age at onset higher than the mean of the entire cohort.ConclusionAccording to our findings, plasma NfL and IAs of HTT gene may represent potential biomarkers in ALS, providing evidence of a possible implication in clinical phenotype.https://www.frontiersin.org/articles/10.3389/fnins.2021.695049/fullamyotrophic lateral sclerosisneurofilament light chainCAG repeat expansionHTT genebiomarkers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Assunta Ingannato Silvia Bagnoli Salvatore Mazzeo Valentina Bessi Sabrina Matà Monica Del Mastio Gemma Lombardi Camilla Ferrari Sandro Sorbi Sandro Sorbi Benedetta Nacmias Benedetta Nacmias |
spellingShingle |
Assunta Ingannato Silvia Bagnoli Salvatore Mazzeo Valentina Bessi Sabrina Matà Monica Del Mastio Gemma Lombardi Camilla Ferrari Sandro Sorbi Sandro Sorbi Benedetta Nacmias Benedetta Nacmias Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients Frontiers in Neuroscience amyotrophic lateral sclerosis neurofilament light chain CAG repeat expansion HTT gene biomarkers |
author_facet |
Assunta Ingannato Silvia Bagnoli Salvatore Mazzeo Valentina Bessi Sabrina Matà Monica Del Mastio Gemma Lombardi Camilla Ferrari Sandro Sorbi Sandro Sorbi Benedetta Nacmias Benedetta Nacmias |
author_sort |
Assunta Ingannato |
title |
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients |
title_short |
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients |
title_full |
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients |
title_fullStr |
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients |
title_full_unstemmed |
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients |
title_sort |
neurofilament light chain and intermediate htt alleles as combined biomarkers in italian als patients |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neuroscience |
issn |
1662-453X |
publishDate |
2021-09-01 |
description |
ObjectiveTo study the possible implication of the two biomarkers, intermediate alleles (IAs) of the Huntingtin (HTT) gene and neurofilament light chain (NfL) levels in plasma, in amyotrophic lateral sclerosis (ALS) patients.MethodsWe analyzed IAs in a cohort of 106 Italian ALS patients and measured the plasma NfL levels in 20% of the patients of the cohort. We correlated the two biomarkers with clinical phenotypes.ResultsIntermediate alleles were present in 7.5% of the patients of our cohort, a frequency higher than that reported in general population. Plasma NfL levels increased with age at onset (p < 0.05). Patients with bulbar onset (BO) had higher plasma NfL concentration (CI −0.61 to −0.06, p = 0.02) and a later age at onset of the disease (CI −24.78 to −4.93, p = 0.006) with respect to the spinal onset (SO) form. Additionally, two of the patients, with IAs and plasma NfL concentration lower with respect to normal alleles’ carriers, presented an age at onset higher than the mean of the entire cohort.ConclusionAccording to our findings, plasma NfL and IAs of HTT gene may represent potential biomarkers in ALS, providing evidence of a possible implication in clinical phenotype. |
topic |
amyotrophic lateral sclerosis neurofilament light chain CAG repeat expansion HTT gene biomarkers |
url |
https://www.frontiersin.org/articles/10.3389/fnins.2021.695049/full |
work_keys_str_mv |
AT assuntaingannato neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT silviabagnoli neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT salvatoremazzeo neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT valentinabessi neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT sabrinamata neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT monicadelmastio neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT gemmalombardi neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT camillaferrari neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT sandrosorbi neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT sandrosorbi neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT benedettanacmias neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients AT benedettanacmias neurofilamentlightchainandintermediatehttallelesascombinedbiomarkersinitalianalspatients |
_version_ |
1717815253343928320 |